Congress · 119th Congress
Top-down approach has Congress AWOL on FDA, experts say
'On its back foot'↵↵Reshma Ramachandran, an assistant professor of medicine at Yale University, said in an interview that the FDA over the past year has engaged with the public much less than it typically